Developing Family Planning Nurse Practitioner Protocols

Hawkins, Joellen W.; Roberto, Diane

doi:10.1111/j.1552-6909.1984.tb01125.x

Cited by 3 publications

(3 citation statements)

References 1 publication

Supporting

Mentioning

Contrasting

Order By: Relevance

“…Expression of unwillingness to receive subsequent anticancer therapy after TKI. Following the charting format of SOAP (subject, object, assessment, and plan) (12), the patient's/family's expression of refusal of all subsequent anticancer therapy after TKIs was described in the patient's chart as it was given. The reason for the refusal was also described as it was given.…”

Section: Methodsmentioning

confidence: 99%

Refusal of Subsequent Treatment in Patients With EGFR-mutant Non-small-cell Lung Cancer After Response to EGFR-TKIs

Hashimoto¹,

Fujii²,

Ujiie³

et al. 2023

CDP

View full text Add to dashboard Cite

Background/Aim: During the course of effective and long-term treatment with epidermal growth factor receptor-tyrosine kinase inhibitor (EGFR-TKI), some elderly patients might decline further treatment after EGFR-TKI. We conducted a study to try and understand the reasons for this treatment decision. Patients and Methods: We analyzed the medical records of all patients diagnosed with non-small-cell lung cancer with EGFR mutations between 2016 and 2021. Results: There were 108 patients who received EGFR-TKIs. Of these, 67 patients responded to TKI. These responding patients were divided into two groups according to whether they received subsequent TKI treatment. At their request, 24 patients (group A) did not receive further anticancer treatment following TKI. The other 43 patients (group B) received anticancer therapy following TKI. Progression-free survival in group A patients was significantly longer (median=18 months, range=1-67 months) than in group B patients. The reasons for not wanting subsequent treatment after TKI were older age, reduced general condition, deterioration of physical comorbid disease and dementia. Dementia was the most common reason for patients over 75 years of age. Conclusion: Some elderly patients with well-controlled disease might express their refusal of all subsequent anticancer therapy after TKIs. Medical staff should respond seriously to these requests.

show abstract

Section: Methodsmentioning

confidence: 99%

Refusal of Subsequent Treatment in Patients With EGFR-mutant Non-small-cell Lung Cancer After Response to EGFR-TKIs

Hashimoto¹,

Fujii²,

Ujiie³

et al. 2023

CDP

View full text Add to dashboard Cite

show abstract

“…The fourth (i.e., plans) includes the proposed future prognosis strategies, including follow-up(s). [1,7,[9][10][11][12] The SOAP note plays one of the central roles in the pharmacists' PCP (PPCP) to achieve the utmost patient care within the integrated health care team. [5] The PPCP approach represents a framework for consistent, quality, and uninterrupted delivery of pharmaceutical services via 5 steps: collect, assess, plan, implement, and follow-up, where the SOAP note may get integrated.…”

Section: Introductionmentioning

confidence: 99%

“…The fourth (i.e., plans) includes the proposed future prognosis strategies, including follow-up(s). [1,7,9–12]…”

Section: Introductionmentioning

confidence: 99%

Community pharmacy-based SOAP notes documentation

Sapkota

Shrestha²,

Giri³

2022

Medicine

View full text Add to dashboard Cite

There is still scarce and sparse evidence regarding documentation of the subjective, objective, assessment and plan (SOAP) note in community pharmacies despite its long implementation history in clinical and academia settings. Hence, we aimed to document and maintain SOAP notes for individual patients visiting community pharmacies for their health problems.We conducted a community-based cross-sectional study at 2 community pharmacies in Nepal from July to December 2019. We recruited 400 patients from all age groups suffering from any health problem using simple random sampling. Patients' subjective complaints were retrieved from their respective prescriptions and verified by interviewing them. Data were collected on the standard format of the SOAP notes and all data related to patients' subjective and objective evaluations, and assessments and plans were descriptively analyzed with R programming 4.0.3. Drug interaction profile was checked with the Medscape Drug Interaction Checker.A total of 87 (21.8%) patients aged 42 to 51 years participated in the research, out of whom 235 (58.8%) were female, 208 (52%) illiterate, 359 (89.8%) were facing mild polypharmacy, and 40 (9.9%) were suffering from joint, leg, ankle, and knee pain. There were 41 minor (11.4%), 130 major (32.7%), and 3 severe (0.9%) drug interaction cases (i.e., medication-related problems), with 11 (2.8%) occurring between amlodipine and metformin, which required close monitoring. There were 226 (56.5%) cases with follow-up planned for the patients when necessary.This novel approach in documenting SOAP notes at community pharmacies during dispensing would be an extended form of the same being applied in clinical settings. Hence, this would open a new arena for the community pharmacists to expand their professionalism beyond the clinical and academia by documenting patients' complex disease and medication profiles in their documentation.

show abstract

Collaboration in developing a protocol for nurse-led seroma aspiration

Warren

2008

Br J Nurs

View full text Add to dashboard Cite

A seroma is a serous fluid collection which may develop in the space between the chest wall and skin flaps following breast cancer surgery with axillary lymph node dissection. Seroma formation following mastectomy is most common. This article aims to produce a protocol for nurse-led seroma aspiration in collaboration with the breast multidisciplinary team and describe the four main steps involved in the development. It was important to develop a protocol for nurse-led seroma aspiration to enable the breast cancer clinical nurse specialist (CNS) to practice confidently and safely in an extended area of practice. The protocol will assist the breast cancer CNS by providing clear and specific guidance. CNSs considering developing a protocol for seroma aspiration should involve all relevant members of the breast multidisciplinary team. Breast cancer CNSs must be trained in seroma aspiration and undergo clinical supervision. Only when deemed competent, should nurse specialists provide a seroma aspiration service independently. Patient satisfaction with the nurse-led seroma aspiration service should be evaluated by clinical audit at an early stage.

show abstract

Developing Family Planning Nurse Practitioner Protocols

Cited by 3 publications

References 1 publication

Refusal of Subsequent Treatment in Patients With EGFR-mutant Non-small-cell Lung Cancer After Response to EGFR-TKIs

Refusal of Subsequent Treatment in Patients With EGFR-mutant Non-small-cell Lung Cancer After Response to EGFR-TKIs

Community pharmacy-based SOAP notes documentation

Collaboration in developing a protocol for nurse-led seroma aspiration

Contact Info

Product

Resources

About